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Many bacterial pathogens promote infection and cause disease by directly injecting into host cells proteins that
manipulate eukaryotic cellular processes. Identification of these translocated proteins is essential to understanding
pathogenesis. Yet, their identification remains limited. This, in part, is due to their general sequence uniqueness, which
confounds homology-based identification by comparative genomic methods. In addition, their absence often does not
result in phenotypes in virulence assays limiting functional genetic screens. Translocated proteins have been observed
to confer toxic phenotypes when expressed in the yeast Saccharomyces cerevisiae. This observation suggests that yeast
growth inhibition can be used as an indicator of protein translocation in functional genomic screens. However, limited
information is available regarding the behavior of non-translocated proteins in yeast. We developed a semi-automated
quantitative assay to monitor the growth of hundreds of yeast strains in parallel. We observed that expression of half
of the 19 Shigella translocated proteins tested but almost none of the 20 non-translocated Shigella proteins nor ;1,000
Francisella tularensis proteins significantly inhibited yeast growth. Not only does this study establish that yeast growth
inhibition is a sensitive and specific indicator of translocated proteins, but we also identified a new substrate of the
Shigella type III secretion system (TTSS), IpaJ, previously missed by other experimental approaches. In those cases
where the mechanisms of action of the translocated proteins are known, significant yeast growth inhibition correlated
with the targeting of conserved cellular processes. By providing positive rather than negative indication of activity our
assay complements existing approaches for identification of translocated proteins. In addition, because this assay only
requires genomic DNA it is particularly valuable for studying pathogens that are difficult to genetically manipulate or
dangerous to culture.
Citation: Slagowski NL, Kramer RW, Morrison MF, LaBaer J, Lesser CF (2008) A functional genomic yeast screen to identify pathogenic bacterial proteins. PLoS Pathog 4(1): e9.
doi:10.1371/journal.ppat.0040009
Introduction
The complete genomes of over 150 bacteria including
many pathogens have been sequenced. Comparative ge-
nomics can predict functions for up to 75% of the annotated
open reading frames (ORFs), the majority of which encode
housekeeping proteins. Nevertheless, the functions of hun-
dreds of proteins typically defy prediction. Included within
this set are bacterial proteins that play a role in the
development of infections. For example, both intra- and
extra-cellular bacterial pathogens, like their viral counter-
parts, affect intracellular processes by directly delivering
proteins into the cytoplasm of host cells by processes such as
type III, type IV and type VI secretion [1–3]. The components
of the complex protein ‘‘machines’’ that mediate trans-
location are relatively well conserved, but their substrates, the
translocated proteins, are poorly conserved and rarely share
detectable translocation signal sequences.
Numerous genome-wide experimental approaches have
been undertaken to identify bacterial proteins involved in
pathogenesis. These include screening banks of transposon-
generated mutants for alterations in pathogenesis [4] as well
as identifying proteins selectively expressed during infec-
tions [5]. Although these screens are effective they are
limited to bacteria that are genetically manipulable and have
susceptible animal or cell culture models. In addition, since
translocated bacterial proteins are often functionally re-
dundant they are often missed in genetic screens for
mutants defective in speciﬁc steps of pathogenesis [6].
Alternative complementary experimental approaches are
needed to facilitate rapid screening of genomes to identify
potential pathogenic proteins on which to focus subsequent
studies.
Although yeast cannot serve as a physiologic model of
human infection, S. cerevisiae is an established organism for
characterizing translocated bacterial proteins that target
conserved eukaryotic physiology. For example, translocated
proteins that alter the mammalian actin cytoskeleton as well
as the secretory and signal transduction pathways have been
demonstrated to target analogous processes in yeast [7–13].
Perhaps unsurprisingly, such targeting is often detrimental to
yeast and results in measurable growth inhibition. This
suggests that yeast growth inhibition is a sensitive indicator
of translocated proteins. Indeed, expression of three of the
ﬁve known Yersinia pseudotuberculosis effector proteins and
four of the eight LEE (locus of enterocyte effacement)
encoded enteropathogenic Escherichia coli effector proteins
inhibit yeast growth [7,14]. Of note, in each of these cases, the
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yeast as fusion proteins.
There is limited information available on the speciﬁcity of
yeast growth inhibition as an indicator of translocated
proteins. A recent genome-wide screen for Legionella pneumo-
philia proteins that inhibit yeast growth suggests that growth
inhibition due to expression of non-translocated proteins is
rare. In this screen that covered ;60% of the Legionella
proteome, fragments of only nine Legionella proteins, three
translocated and six non-translocated proteins, inhibited
yeast growth [8]. However, this study was likely limited
because each Legionella protein fragment was fused to the
classic SV40 nuclear localization signal, a hemagglutinin
epitope tag and the acidic transcription activation domain of
B42. Since fusion to the SV40 NLS is often sufﬁcient to direct
nuclear localization of normally cytoplasmic proteins, altered
targeting could interfere with the activity of Legionella
proteins. Similarly, the acidic activation domain could
disrupt function. Furthermore, the Legionella proteins were
expressed at relatively high levels in yeast.
The observations summarized above suggested that yeast
growth inhibition could be used as a functional genomic
screen to identify previously unknown virulence proteins that
target host cells. In order to determine if this is indeed the
case as well as to optimize such screens, we systematically
characterized the behavior in yeast of known translocated
and non-translocated bacterial proteins when expressed at
either relatively high or low-levels on their own or fused to
GFP. We developed an economical high throughput growth
assay to facilitate such studies on a genome-wide scale. We
observed that expression of half of the 19 Shigella translocated
proteins tested but almost none of the 20 non-translocated
Shigella proteins nor .1,000 F. tularensis proteins signiﬁcantly
inhibit yeast growth. Not only does this study establish that
yeast growth inhibition is a sensitive and speciﬁc indicator of
translocated proteins, but we also identiﬁed a new substrate
of the Shigella type III secretion system (TTSS), IpaJ,
previously missed by other experimental approaches. These
observations demonstrate that yeast growth inhibition can be
used as a functional genomic screen to identify pathogenic
proteins.
Results/Discussion
Selection of Shigella Proteins from Virulence Plasmid for
Yeast Growth Assays
Shigella, the causative agent of bacterial dysentery, is an
intracellular pathogen that mediates its own uptake and
subsequent dissemination between host cells in part by the
action of translocated effector proteins (for review [15]). All
pathogenic Shigella species contain a virulence plasmid that
encodes ;106 full-length ORFs including one of the largest
known sets of proteins translocated by a TTSS [16,17]. This
plasmid encodes at least 14 known substrates of the TTSS
[18–23] as well as seven additional proteins have been
proposed to be TTSS substrates based on homology [16]. A
third of these ORFs are organized within two operons
required for entry of Shigella into host cells. These operons
encode components and regulators of a TTSS as well as a few
translocated proteins [16,17]. The GC-content of all 34 genes
present in these two operons is ;34% while the GC-content
of Shigella chromosomal genes is generally .50%. Twenty-two
additional low GC-content (,40%) genes are present
throughout the virulence plasmid. The low GC-content of
these genes suggests that many also encode proteins involved
in virulence. Indeed many of these genes encode translocated
proteins [16]. The virulence plasmid also encodes two
autotransporters, one of which, IcsA, is delivered directly
into host cells once the Shigella are internalized [24]. Because
it contains a combination of known translocated and non-
translocated proteins the virulence plasmid was initially
treated as a ‘‘mini genome’’ to determine the relative
sensitivity and speciﬁcity of yeast growth inhibition as an
indicator of translocated pathogenic proteins.
We expressed three groups of proteins from the Shigella
ﬂexneri virulence plasmid in yeast. The ﬁrst group was
composed of 18 proteins translocated by Shigella into host
cells (Table 1). The second group was composed of 20
proteins that are conﬁned to the bacterium during infection
(non-translocated). This group includes proteins involved in
plasmid segregation, transcriptional regulation and TTSS
chaperones (Table 2). The third group was composed of three
candidate translocated proteins based on the low GC-content
of their corresponding genes (orf13, orf212 and ipaJ). Shigella
proteins that interact with the bacterial outer membrane as
well as the components of the TTSS apparatus were not
expressed in yeast because of concern that such membrane
associated proteins would not correctly fold when expressed
de novo in yeast.
Development of a Quantitative Yeast 96 Well Liquid
Growth Assay
Several considerations determined the design of our
quantitative yeast growth assay. First, heterologous proteins
can be introduced and maintained in yeast by integrating
their genes into the yeast chromosome, a labor-intensive
strategy, or by carrying the genes on a plasmid. Two such
plasmids that differ in their mechanism of plasmid main-
tenance and copy number are commonly used in yeast. The
ﬁrst class of plasmids referred to as 2l plasmids are
maintained at a copy number of 30–50. The second class
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Author Summary
Many bacterial pathogens promote infection and ultimately cause
disease, in part, through the actions of proteins that the bacteria
directly inject into host cells. These proteins subvert host cell
processes to favor survival of the pathogen. The identification of
such proteins can be limited since many of the injected proteins lack
homology with other virulence proteins and pathogens that no
longer express the proteins are often unimpaired in conventional
assays of pathogenesis. Many of these proteins target cellular
processes conserved from mammals to yeast, and overexpression of
these proteins in yeast results in growth inhibition. We have
established a high throughput growth assay amenable to system-
atically screening open reading frames from bacterial pathogens for
those that inhibit yeast growth. We observe that yeast growth
inhibition is a sensitive and specific indicator of proteins that are
injected into host cells. Expression of about half of the injected
bacterial proteins but almost none of the bacteria-confined proteins
results in yeast growth inhibition. Since this assay only requires
genomic DNA it is particularly valuable for studying pathogens that
are difficult to genetically manipulate or dangerous to grow in the
laboratory.referred to as centromere (cen) containing plasmids are
maintained at a copy number of 1–3. Second, two methods
are commonly use to conﬁrm expression of heterologous
proteins in yeast. Antibodies can be raised against each
protein or proteins can be tagged with a common epitope.
Because raising antibodies would be prohibitively laborious
in a large screen, we chose the simpler epitope approach.
Thus, genes encoding each of the chosen Shigella proteins
were cloned as GFP fusion proteins on both high and low
copy plasmids under the control of an inducible promoter
(GAL10). GFP was used as the epitope to enable future
localization studies.
Traditionally quantitative yeast growth assays involve
generating growth curves based on frequent optical density
(OD) readings of individual aerated cultures grown in test
tubes. Recently it was demonstrated that yeast growth in
microscale (350 microliter) liquid cultures parallels that
observed in larger cultures [25]. In this assay, a single 96-
well plate is incubated at 308C in a plate reader. The plates
are shaken at regular intervals to promote aeration and OD
readings are obtained every 20 minutes for 24 hours. This
assay produces growth curves very similar to the larger
volume methods, but it requires the dedication of a plate
reader for 24 hours to a single set of 96 cultures.
Alternatively, the commercially available Phenotypic Micro-
Array technology (Biolog) allows for simultaneous monitor-
ing growth rates from numerous 96-well plates using
proprietary technology [4]. However, this technology is
relatively costly.
We adapted the microscale method to develop a growth
assay to measure the growth of thousands of cultures in
parallel. In our assay yeast are incubated at 308C without
agitation in 96-well plates. The OD600 of each well is read at
24, 30, 36, 48 and 52 hours, corrected for nonlinearity (Figure
S1), and smooth growth curves are spline interpolated
through the 5 time points. Although yeast grow more slowly
in these non-aerated conditions, the growth curves exhibit
the expected lag, exponential, and log phases (Figure S2).
Moreover, because the area under the curves is highly
correlated with the 48hr time points, a single 48hr measure-
ment actually sufﬁces to assess relative effects. Thus, all
subsequent analyses presented herein are based exclusively
on the 48hr time points.
Enrichment of Growth Phenotypes Conferred by
Expression of Translocated Shigella Proteins
Figure 1 summarizes the yeast growth phenotypes due to
expression of each of the Shigella proteins when expressed as a
GFP fusion protein from either a low or high copy number
plasmid. Under both conditions, expression of the trans-
located proteins resulted in more frequent and more severe
growth inhibition than the non-translocated proteins. The
growth phenotypes resulting from expression of the Shigella
proteins fell into three classes: severe, moderate and minimal
to no growth inhibition.
Expression of six Shigella proteins completely inhibited
yeast growth under all conditions tested. These include four
translocated proteins (VirA, IcsB, IpgB2 and IpgD), one non-
translocated protein (MvpT), and one protein of unknown
secretory status (IpaJ). Expression of four additional trans-
located proteins (OspC1, OspF, IpgB1 and OspD3) and one
non-translocated protein (ParA) conferred intermediate
inhibitory growth phenotypes when expressed at low-levels
in yeast. Several additional translocated and non-translocated
proteins moderately inhibited growth when expressed at high
levels.
Overall, low-level expression of the bacterial proteins
increased the speciﬁcity while high-level expression increased
the sensitivity of growth inhibition as an indicator of
translocated proteins (Figure 1A vs. 1B). Although, in general,
under both conditions tested, expression of the translocated
proteins resulted in greater growth inhibition than the non-
translocated proteins. Thus, the speciﬁcity of the assay for
Table 1. Summary of Known Status of Translocated Proteins
Protein Secreted Translocated Activity
icsA Autotransporter N-WASP recruiting protein [56]
icsB þþ Inhibits autophagy [57]
IpaA þþ Vinculin binding protein [58]
IpaH1.4
a Putative E3 ubiquitin ligase [53]
IpaH4.5 þ Putative E3 ubiquitin ligase [53]
IpaH7.8 þ Putative E3 ubiquitin ligase [53]
IpaH9.8 þþ E3 ubiquitin ligase [53]
IpgB1 þþ G-protein mimic [59]
IpgB2
a G-protein mimic [30]
IpgD þþ Inositol phosphate phosphatase [60]
OspB þ Unknown
OspC1 þ Unknown
OspD1 þ Unknown
OspD2
a Unknown
OspD3
a Unknown
OspE2 þ Co-localizes with focal contacts [59]
OspF þþ MAPK phosphothreonine lyase [59]
VirA þþ Microtubule-severing activity [60]
aHomolog of known translocated protein.
doi:10.1371/journal.ppat.0040009.t001
Table 2. Summary of Functions of Non-translocated Proteins
Protein Function
acp Periplasmic acid phosphatase
ccdA Antitoxin-plasmid segregation
fin0 Transfer of plasmids
ipgA TTSS chaperone
ipgC TTSS chaperone
ipgE TTSS chaperone
ipgF TTSS chaperone
msbB Lipid A modification
mvpA Antitoxin-plasmid segregation
mvpT Toxin- plasmid segregation
parA Plasmid segregation
parB Plasmid segregation
PhoN2 Periplasmic acid phosphatase
stbA Plasmid segregation
stbB Plasmid segregation
traX Transfer of plasmids
trbH Unknown
ushA Periplasmic UDP-sugar hydrolase
virB Transcriptional activator
virF Transcriptional activator
doi:10.1371/journal.ppat.0040009.t002
PLoS Pathogens | www.plospathogens.org January 2008 | Volume 4 | Issue 1 | e9 0098
Functional Genomic Screen for Effectorsdetection of translocated proteins improves when focusing
on proteins whose expression inhibits growth more severely.
Expression of GFP-IpgB2 was so toxic to yeast that we were
only able to obtain healthy yeast transformants that carry the
fusion gene on a low but not a high-copy number plasmid
even under conditions that repress the GAL10 promoter. This
is presumably due to low-level basal expression from the
GAL10 promotor in the presence of glucose [26].
Growth Inhibition Corresponds with Targeting of
Conserved Cellular Processes
In the few cases where the activities of the translocated
Shigella proteins are known, the targets of the proteins that
conferred moderate to severe yeast growth inhibition are
conserved between yeast and humans. Speciﬁcally, VirA [21],
IpgD [18], OspF [27–29] and IpgB1 [23] and IpgB2 [30], target
microtubules, inositol phosphate signaling, mitogen activated
protein kinases and G-protein signaling, respectively. Con-
versely, the translocated protein IpaA [31], which interacts
with vinculin, a protein not present in S. cerevisiae, had no
effect on yeast when grown expressed at low-levels and only
weakly inhibited yeast growth when expressed at high-level.
Expression of two non-translocated bacterial proteins,
MvpT and ParA, also resulted in marked growth inhibition.
MvpT is a bacterial toxin that kills bacteria in the absence of
Figure 1. Growth Phenotypes Conferred by Expression of Shigella GFP Fusion Proteins in Yeast
Each box-and-whisker plot summarizes the OD600 measurements of 22 independent yeast cultures expressing the same bacterial protein at t ¼ 48 h.
The upper panel shows growth of yeast expressing GFP-Shigella fusion proteins encoded on a low-copy number centromere-containing plasmid. The
lower panel shows the growth of yeast expressing the GFP-Shigella fusion proteins encoded on a high copy number 2l plasmid. Proteins shown in
yellow represent those whose expression resulted in a significant reduction in growth when compared to the control (p , 0.001 in a Wilcoxon two-
sample test with Bonferroni correction). In the lower panel, "Control" refers to yeast that express low-levels of GFP, while in the upper panel "Control"
refers to yeast that express high-levels of GFP. The boxes enclose approximately one quartile either side of the median. The whiskers delimit the ;95%
confidence interval for the mean (using default rendering parameters in the statistical computing software package R [55]).
Growth measurements for GFP-MvpT expressed from a yeast low-copy number plasmid are unavailable since we were unable to transform E. coli with
this plasmid, which replicates at very high levels in bacteria. Since the yeast GAL1 promotor is weakly active in bacteria, we hypothesize that low-level
expression of MvpT, a known bacterial toxin, from a high copy number bacterial plasmid results in a toxic bacterial phenotype.
doi:10.1371/journal.ppat.0040009.g001
PLoS Pathogens | www.plospathogens.org January 2008 | Volume 4 | Issue 1 | e9 0099
Functional Genomic Screen for Effectorsits antitoxin, MvpA [32]. Co-expression of MvpA suppressed
MvpT toxicity in yeast as it does in bacteria (data not shown).
Other bacterial toxin-antitoxin systems have been previously
observed to behave similarly in yeast [33,34]. ParA is involved
in plasmid partitioning and its close homolog, Bacillus Soj,
forms nucleoprotein ﬁlaments in vitro [35]. This protein
localizes to the yeast nucleus (unpublished data) suggesting
that it has a conserved interaction with DNA. Thus, growth
inhibition due to MvpT and ParA expression also appear to
be due to targeting of conserved cellular processes though in
these cases the bacterial proteins likely target basic cellular
processes conserved among yeast and prokaryotes.
We were unable to clone mvpT onto a low-copy yeast
expression plasmid in bacteria without generating mutations
in the gene encoding MvpT. However, we were able to clone
this gene on to a high-copy number plasmid. Of note the
yeast low-copy number plasmid is a high copy number (pUC
based, copy number 500–700) bacterial plasmid while the
yeast high-copy number plasmid is a low copy number (pBR
based, copy number 15–20) bacterial plasmid. Thus, we
hypothesize that the low-level expression in bacteria of
GFP-MvpT from the GAL10 promotor or a cryptic bacteria
promotor from the high-copy number bacterial plasmid is
lethal.
Growth Inhibition Is a Specific Indicator of Translocated
Proteins
Our pilot screen with proteins encoded on the Shigella
virulence plasmid suggested that yeast growth inhibition is
both a sensitive and speciﬁc indicator of translocated
bacterial proteins. However, this screen only analyzed the
effects due to expression of 20 non-translocated proteins.
Since these non-translocated proteins are encoded on a
virulence plasmid, there was an inherent bias in this screen
towards bacterial proteins involved in plasmid maintenance/
segregation and regulation of type III secretion. This bias
might overestimate the speciﬁcity of yeast growth inhibition
for detection of translocated proteins since it is conceivable
that bacterial housekeeping proteins involved in cellular
processes highly conserved among prokaryotes and eukar-
yotes might act as dominant negative alleles to inhibit yeast
growth. For example, expression of Legionella sterol desatur-
ase, a homolog of S. cerevisiae ERG25 an essential protein
involved in ergosterol biosynthesis [36], results in yeast
growth inhibition [8]. Thus, we set out to systematically
examined the effects on yeast growth due to a comprehensive
collection of ORFs encoded within a bacterial genome by
taking advantage of the availability of a library of annotated
Francisella tularensis subspecies tularensis (strain SCHU S4) (F.
tularensis) ORFs cloned into a recombination-based cloning
vector [37,38].
F. tularensis is the causative agent of tularemia. Like S.
ﬂexneri, F. tularensis is a gram-negative intracellular pathogen.
Based on comparative genomic analyses and extensive path-
way prediction modeling, a putative function has been
assigned to approximately two-thirds of the ;1,600 anno-
tated F. tularensis ORFs [39]. These include ORFs involved in
metabolism, transcription, and translation. Since Francisella
encodes homologs of common bacterial housekeeping genes,
a survey of the behavior of Francisella proteins in yeast should
provide insight into how other bacterial genomes would
behave when expressed in yeast.
Based on the results of our pilot screen, we decided to
transfer each Francisella ORF to a low-copy number yeast
expression vector such that each ORF was expressed as a GFP
fusion protein under the control of the GAL1 promotor. We
constructed a yeast expression plasmid compatible with the
Gateway recombination-based system to facilitate transfer of
the sequence-veriﬁed Francisella ORFs. Each of the trans-
located Shigella proteins conferred similar effects on yeast
growth when expressed from either the original ‘‘traditional’’
low-copy number yeast expression plasmid or the newly
constructed recombination-based cloning vector (Figure S3).
We successfully transferred approximately two-thirds of the
annotated F. tularensis ORFs into a yeast expression plasmid.
Each ORF was transformed into yeast and up to six biologic
replicates were analyzed for growth inhibition under the
same conditions used to analyze yeast expressing the Shigella
proteins (Table S1).
Expression of none of the Francisella proteins screened
severely inhibited yeast growth and expression of only three
Francisella proteins resulted in minimal but reproducible
growth inhibition (Figures 2 and S4). These proteins include
FTT1130c (CphA, cyanophycin synthetase), FTT0396 (ParC,
topoisomerase IV subunit A) and FTT0384c (a phosphatidyl-
serine decarboxylase (psd)). parC and psd are likely house-
keeping genes and were recently identiﬁed as essential F.
novicida genes in a transposon library screen [40]. Cyanophy-
cin synthetase is involved in synthesis of cyanophycin, a non-
ribosome amino acid polymer common to cyanobacteria. The
signiﬁcance of the presence of this compound in Francisella is
currently unknown.
We next examined the levels of expression of the bacterial
GFP fusion proteins in yeast to determine whether the lack of
growth inhibition was due to poor expression of the Francisella
proteins. The majority of the 48 Francisella and 39 Shigella
proteins examined were expressed at comparable levels
(Figure S5). However, expression of approximately 33% of
the Francisella proteins and 15% of the non-toxic Shigella
proteins was undetectable (expression of three of the ﬁve
toxic translocated proteins was undetectable presumably due
to their associated severe growth inhibition). The signiﬁcance
of the decreased level of expression of the Francisella proteins
is unclear, but may reﬂect their relative decreased G-C
content (32.6%) as compared to the Shigella (39.8%) and
endogenous yeast proteins (38.3%). Alternatively, if we
assume that all of the toxic proteins are expressed in yeast,
then all but two of the translocated proteins (89%) were
expressed in yeast, which suggests that these proteins have
been selected forstability in eukaryotic cells. Thus, the relative
decreased stability of the Francisella proteins might be due to
optimization of their stability in prokaryotic as compared to
eukaryotic cells.
In regards to the sensitivity of growth inhibition for
detection of translocated Francisella proteins, the signiﬁcance
of the scarcity of yeast growth inhibition is unclear. There is
currently no data to demonstrate that F. tularensis secrete
proteins directly into host cells [41]. These bacteria do not
appear to encode type III, type IV or type V secretion systems.
However, some species of Francisella secrete proteins via type
IV pili [42] (although there is no evidence that this secretion
system is functional in F. tularensis) and F. tularensis does
appear to encode a type VI secretion system [43–45]. Since we
have only screened approximately 2/3 of the annotated
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screen would identify potential translocated proteins. Sim-
ilarly, it is possible that translocated Francisella proteins are
expressed too poorly in yeast to interfere with yeast growth
and that increased levels of expression from a high copy
number plasmid might result the sensitivity of detection of
translocated F. tularensis proteins.
Nevertheless, the rarity of growth inhibitory phenotypes
observed with expression of both F. tularensis and non-
translocated S. ﬂexneri proteins in yeast demonstrates that
yeast growth inhibition is a rare event and not due to random
overexpression of bacterial proteins. Furthermore, since
;50% of Francisella ORFs have E. coli homologs [40] it seems
likely that proteins from other gram-negative will behave
similarly when expressed in yeast. Thus, growth inhibition
appears to be a highly speciﬁc indicator of translocated
proteins.
The Addition of Stressors Increases Detection of
Translocated Proteins
Presumably, the targets of some translocated proteins are
not conserved among yeast and mammals and thus expression
of these proteins will not affect yeast growth. Alternatively, a
translocated protein may target a pathway that is conserved
but is not normally rate-limiting for yeast growth. To address
the latter possibility, yeast expressing all 42 Shigella GFP fusion
proteins at low-levels were grown in the presence of four well-
characterized yeast stressors: salt, nocodazole, sorbitol and
Figure 2. Growth Phenotypes Conferred by Expression of Francisella GFP Fusion Proteins in Yeast
Each box-and-whisker plot summarizes the OD600 measurements of six independent yeast cultures expressing the same bacterial protein at t ¼ 48h.
Yeast strains expressing each of the proteins are ordered by their mean OD600 reading. The boxes enclose approximately one quartile either side of the
median. The whiskers delimit the ;95% confidence interval for the mean (using default rendering parameters in the statistical computing software
package R [55]). A blow-up of the first 100 yeast strains displayed in this graph is displayed in Figure S4.
doi:10.1371/journal.ppat.0040009.g002
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impact wild-type growth. High salt and sorbitol both increase
osmotic stress while high salt also results in a disturbance in
ion homeostasis, nocodazole, destabilizes microtubules and
caffeine has pleiotropic affects on yeast including inhibition
of MAP kinases and calcium channels.
The addition of the stressors to the media elicited marked
changes in the phenotypes of two translocated proteins
(Figure 3). OspB weakly inhibited growth in standard
conditions, but in the presence of caffeine low-level OspB
expression severely inhibited yeast growth. The phenotype of
IcsA was similarly ampliﬁed by the addition of nocodazole.
Although these were the only strictly conditional phenotypes,
yeast expressing proteins that conferred intermediate growth
phenotypes when expressed at low-levels (IpgB1, OspC1,
OspD3, OspF and ParA) displayed different sensitivities to
the four stressors, implying that the phenotypes conferred by
each of these proteins is due to a speciﬁc activity of the
protein. In summary, the stress conditions increased the
sensitivity of the assay with no loss of speciﬁcity.
We assayed for growth inhibition in the presence of four
well-characterized yeast stressors; however, there are numer-
ous other agents that could also be applied. The potential
value of such assays goes beyond the identiﬁcation of proteins
whose targets are not limiting for growth. The patterns of
sensitivities of yeast expressing the bacterial proteins to
individual stressors might provide insights into cellular
processes targeted by the proteins. For example, the
sensitivities of the complete set of ;4,700 viable yeast
deletion strains to dozens of stressors have been measured
[46,47]. Thus, it should be possible to compare sensitivity
patterns of the yeast deletion strains and yeast expressing
bacterial proteins. The yeast genome is one of the most
exhaustively characterized of any organism, so similarities in
the patterns of sensitivities to various stressors between yeast
deletion strains and wild type yeast expressing a given
bacterial protein can potentially provide insight into the
activity of the bacterial proteins. Such strategies have been
successfully applied to identify the cellular targets of
therapeutic agents [47,48].
Fusion to GFP Generally Exacerbates Rather Than Masks
Growth Inhibition
Another explanation for the lack of detection of yeast
growth inhibition due to expression of bacterial proteins is
that fusion to GFP could potentially interfere with the
activity and/or folding of the proteins and thus mask
phenotypes. To address this possibility we conducted growth
assays on yeast that express the Shigella proteins in the
Figure 3. The Addition of Stressors Elicits Additional Yeast Growth
Inhibition Phenotypes by Translocated Proteins
The heatmap summarizes the relative growth at t ¼ 48 h of yeast that
express the Shigella GFP fusion proteins or GFP grown under each of five
conditions: no stressor, 6 mM caffeine, 3 lg/ml nocodazole, 0.5 M
sorbitol, and 0.5M NaCl. Each cell represents the mean OD600 measure-
ments at 48 h of six independent yeast colonies expressing the same
bacterial protein from a low-copy yeast expression plasmid grown under
the same condition. Rows and columns were clustered by the complete
linkage algorithm using the standard Euclidean distance metric operat-
ing directly on data vectors (i.e., without normalization). The proteins
labeled in red are translocated, those labeled in black are non-
translocated, and the unknowns in blue. GFP control is labeled in gray.
doi:10.1371/journal.ppat.0040009.g003
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Functional Genomic Screen for Effectorsabsence of GFP. The absence of GFP decreased the overall
toxicity of almost all the Shigella proteins when expressed
from a high-copy number plasmid (Figure 4 vs. Figure 1).
High-level expression of all the Shigella GFP fusion proteins
inhibited growth more often than their non-GFP counter-
parts (75% vs. 38%).
In general, proteins that conferred the weakest growth
phenotypes when fused to GFP and expressed at high-levels,
no longer resulted in signiﬁcant growth inhibition when
expressed on their own or when expressed as GFP fusion
proteins at relatively low-levels in yeast. In the extreme case,
IpgB1, a strong growth inhibitor when fused to GFP,
conferred no detectable inhibition when expressed without
GFP. Nevertheless, fusion to GFP appears to interfere with
the activity of StbB and OspF, though only in the case of StbB
was the growth inhibition phenotype entirely masked. Over-
all, these observations suggest that, in general, fusion to GFP
increased the stability of the fusion proteins [49] and/or the
transcriptional efﬁciency of the genes encoding the Shigella
fusion proteins without disrupting their function.
IpaJ Is a Substrate of the Shigella Type III Secretion System
Of the three proteins of unknown function we expressed in
yeast, only one, IpaJ, resulted in yeast growth inhibition. To
determine if we had identiﬁed a new substrate of the Shigella
TTSS, a plasmid that encodes IpaJ fused to 3x FLAG tag was
introduced into wild type Shigella strain as well as a Shigella
strain defective in TTSS due to a mutation in mxiM1 [50], a
component of the secretion apparatus. As demonstrated in
Figure 5A, IpaJ is only detected by western blot analyses in
the supernatants of wild-type Shigella after the addition of
Congo red, a TTSS inducer, to the media [51]. Similarly, as
shown in Figure 5B, detectable levels of IpaJ within host cells
during the course of an infection is also dependent on an
intact TTSS. Secretion of IpaJ appeared to be ;100 times
lower than that of either IpgB1 or OspF (data not shown).
This difference in secretion levels may explain the lack of
detection of IpaJ in prior analyses of native proteins in
supernatant preparations of Shigella mutants that constitu-
tively secrete effector proteins [16]. Thus, our growth
inhibition screen led to the identiﬁcation of a new effector
protein that had been previously missed by other exper-
imental approaches.
Summary
We have developed a semi-automated quantitative yeast
assay to measure the growth of thousands of strains in
parallel. Using this system, we demonstrate that yeast growth
inhibition is a relatively speciﬁc and sensitive indicator of
translocated bacterial proteins that target host cells. The
efﬁciency of our growth assay combined with the increasing
availability of bacterial genomes in recombination-based
cloning vectors [52] which are easily transferred to yeast
expression vectors, makes this assay a compelling functional
genomic screen for the identiﬁcation of translocated pro-
teins. In particular, because it only requires DNA, the yeast
growth assay is invaluable for studying organisms difﬁcult or
dangerous to grow. Furthermore, once a library of yeast
expressing bacterial proteins is generated, additional high
throughput assays can be designed to screen for bacterial
proteins that target speciﬁc conserved eukaryotic cellular
pathways. For example, Shohdy and colleagues used a
reporter plasmid to screen for Legionella pneumophila proteins
that interfere with yeast membrane trafﬁcking [10]. Similarly,
Rhode and colleagues identiﬁed a Shigella effector, IpaH9.8
that speciﬁcally inactivates the yeast mating pathway, a highly
Figure 4. Growth Phenotypes Conferred by Expression of Shigella Proteins in Yeast
Each box-and-whisker plot summarizes the OD600 measurements of 22 independent yeast cultures expressing a single Shigella protein at t ¼ 48 h.
Proteins shown in yellow represent those whose expression resulted in a significant reduction in growth when compared to the control (p , 0.001 in a
Wilcoxon two-sample test with Bonferroni correction). ‘‘Control’’ refers to yeast that carry empty vector. The boxes enclose approximately one quartile
either side of the median. The whiskers delimit the ;95% confidence interval for the mean (using default rendering parameters in the statistical
computing software package R [55]).
doi:10.1371/journal.ppat.0040009.g004
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Functional Genomic Screen for Effectorsconserved MAPK signaling pathway, by targeting a mitogen
activated kinase kinase for degradation via ubiquination [53].
Lastly, prior work has established that detailed understanding
of a protein’s activity in yeast can provide insights into its
activity in more complex organisms [7–13]. Thus, bacterial
proteins that inhibit yeast growth are obvious candidates for
future studies in yeast to determine the molecular mecha-
nisms underlying growth inhibition.
Materials and Methods
Plasmids and strains. The Shigella genes cloned into the yeast
expression vectors are summarized in Table S2. Each designated open
reading frame was PCR ampliﬁed from a 2457T S. ﬂexneri serotype 2a
DNA preparation. Genes were subcloned into two high copy number
(2l) plasmids (copy number 30–50) that carry the LEU2 gene and the
GAL10 promoter, pFUS-GFP and pFUS-HIII [7]. The genes were
either cloned in-frame with the carboxy-terminus of GFP (pFUS-GFP)
or in-frame with a short sequence between the pFUS-HIII start codon
and polylinker. The primers used for ampliﬁcation via the polymer-
ase chain reaction (PCR) contained engineered restriction sites at
their 59 (ApaI or XhoI) and 39 (NheI) ends. When the ApaI site was
introduced, the bacterial gene ATG was converted to CTG, thus
converting methionine to leucine. The icsB gene, which contains an
NheI site, was cloned directly into the pFUS vectors by homologous
recombination in yeast. Each of the PCR-ampliﬁed genes was
analyzed by DNA sequencing. The sequences were compared to the
sequence of the Shigella ﬂexneri serotype 2a strain 2457T virulence
plasmid (generously provided by Dr. Val Burland (University of
Wisconsin)). With the exception of two synonymous mutations all of
the sequence changes had been previously observed. Sequence
variations speciﬁc to the 2457T virulence plasmid as compared to
the published Shigella virulence plasmids are summarized in Table S2.
Low-copy-number (centromere-containing) plasmid (copy number
1–3) versions of the clones were constructed by homologous
recombination gap repair into pRS313 that contains the GAL10
promotor/GFP and terminator regions of the pFUS plasmid.
The sequence-veriﬁed Francisella genes present in the Gateway
pDNR entry vector were transferred to pBY011-GFP-clonNAT by a
Gateway LR reaction. pBY011-GFP-clonNAT is a derivative of
pBY011-D123. The gene encoding GFP was introduced downstream
of the GAL1–10 promotor and upstream of the attR1 site at the XbaI
site. The clonNAT gene was introducing at the site in pBY011-D123.
All yeast expression plasmids were transformed into wild-type yeast
strain S288C (BY4741 MATa) using the PEG/Lithium acetate method.
Yeast growth assays. Growth phenotypes of yeast that condition-
ally express the Shigella proteins were assayed in 96-well plates.
Individual yeast transformants were inoculated into each well of a 96-
well plate containing non-inducing selective synthetic media supple-
mented with 4% glucose. Saturated cultures were transferred to non-
inducing selective synthetic solid media, 4% glucose using a 3.18 mm
diameter 96-pinner tool (V&P Scientiﬁc, Inc., San Diego, CA) on a
Biorobot 3000 (Qiagen, Valencia, CA). After one to two days, the yeast
spots on the solid plates were transferred to fresh liquid 96-well
plates using a 1.58 mm diameter 96-pinner tool and incubated 16–18
hours to grow to OD600 between 0.3–0.4. The liquid cultures were
next transferred with 1.58mm diameter pinner to inducing selective
synthetic liquid media containing 4% galactose in 96-well plates
(‘‘induction plates’’). All incubations were done at 308C and in the
absence of agitation. In the case of the stressors, selective synthetic
liquid media containing 4% galactose was supplemented with 500
mM sodium chloride, 6 mM caffeine, 0.5 M Sorbitol, and 3 lg/ml
nocodazole. Growth in the 96-well plates was monitored by OD600
readings with a Wallac Victor II multiplate reader (Perkin Elmer,
Shelton, CT) at 24, 32, 40, 48 and 52 hours. The plates are shaken
prior to being read in plate reader to allow for even distribution of
colonies in the media.
Screening for yeast growth inhibition due expression of F. tularensis
proteins. Thirteen hundred and seven individual annotated F.
tularensis Schu 4 sequence-veriﬁed open reading frames were trans-
ferred from a Gateway entry vector to pBY011-GFP-clonNAT, a yeast
expression plasmid, using Gateway technology (Invitrogen). Thirty-
seven of these reactions failed to yield bacterial transformants and
were dropped from the screen. Plasmids were subsequently isolated
from the remaining 1270 transformants. On two separate occasions,
DNA from these transformants was transferred into wild type yeast
(S288C) using a yeast 96-well transformation protocol using a 3.18
mm diameter 96-pinner tool. In each case, the transformants were
selected on three independent 96-well plates, thus a total of
potentially six independent yeast transformations were examined
for each clone. A 96-pinner device with 1.58 mm pins was then used
to transfer a subset of the transformants to a second solid media SC-
URA non-inducing tray to allow for ‘‘normalization’’ of the amount
of yeast recovered from each transformation. Yeast containing each
of the Francisella ORFs were subjected to the 96 well liquid growth
assay described above.
As summarized in Table S1 the majority of the plasmids (1116)
were successfully transformed in each of the six biologic replicates. In
the 165 cases where six transformants were not obtained, the
plasmids used to transform the yeast were examined by gel electro-
phoresis. Of these 165 plasmids, 61 were observed to have undergone
an incorrect recombination event during the Gateway reaction and
thus were classiﬁed as additional Gateway failures. We then
restriction digested 50 of the plasmids used in the successful yeast
transformations. Five of these plasmids demonstrated incorrect
restriction patterns suggesting that ;10% of the remaining Gateway
reactions were incorrect. Thus, we estimated that we have successfully
screened for growth phenotypes due to expression of ;1,000 F.
tularensis ORFs.
Several observations suggest that the lack of detection of Francisella
proteins that inhibit yeast growth is not due to false negatives. First,
we did initially identify four Francisella ORFs that appeared to
signiﬁcantly inhibit yeast growth. Thus, our screen was indeed
capable of identifying yeast strains impaired in growth. However,
upon further analysis, it was apparent that the plasmid introduced
into these strains, also resulted from an incorrect recombination
event such that the plasmid no longer encoded a Francisella ORF.
Indeed this plasmid was smaller than expect and yeast carrying this
plasmid were impaired for growth under both inducing (galactose)
and non-inducing (glucose) conditions. Second, based on the
Figure 5. IpaJ Secretion and Translocation Are Dependent on an Intact
Type III Secretion System
(A) Wild-type and BS547 (mxiM1) [50] Shigella, a TTSS-defective strain,
that carry a low-copy number plasmid that expresses IpaJ-FLAG from its
endogenous promotor were grown in the presence of Congo Red, an
inducer of the Shigella TTSS. Proteins from culture supernatants and
whole-cells were separated by SDS-PAGE and subjected to western blot
analyses with anti-FLAG antibody.
(B) HeLa cells were infected with either wild-type or BS547 (mxiM1)
Shigella that express IpaJ-FLAG at an MOI of 100:1. One hour after
infection, the cells were lysed and fractionated into soluble and insoluble
fractions. Proteins from each fraction were separated by SDS-PAGE and
subjected to western blot analyses with anti-FLAG antibody. Trans-
located proteins are found in the soluble fraction, while those from
unlysed bacteria are found in the insoluble fraction.
doi:10.1371/journal.ppat.0040009.g005
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Functional Genomic Screen for Effectorsbehavior of the known blanks and gateway recombination failures
there was a low-rate of cross-contamination. Only 12.9% of the
expected blank spots showed any growth. Thus, it is extremely
unlikely that .1 of the 6 transformants of each Francisella ORFs
screened was contaminated. Furthermore, examination of the
original transformation plates demonstrates that when there is a
contaminant, the most likely source is at the time of transformation
and the rate of contaminant is minimal.
Yeast western blot assays. Yeast that conditionally expressed each
of the Shigella translocated and non-translocated proteins studied as
well as 48 Francisella proteins fused to GFP were grown overnight in
selective media supplemented with 2% rafﬁnose. In the AM, cultures
were back-diluted to OD600 ¼ 1.0 in selective media supplemented
with 2% rafﬁnose. After 2 hours, protein production was induced by
the addition of galactose to a ﬁnal concentration of 4%. After an
additional 4 hours, the yeast were pelleted and quickly frozen in a
dry-ice/ethanol bath. The yeast were subsequently lysed using a bead-
beat protocol and equal volumes of samples were analyzed by SDS-
PAGE and subjected to western blot analyses with anti-GFP
polyclonal antibody (Sigma). PSTAIRE antibody (Santa Cruz Bio-
technology) was used to monitor levels of Cdc2 as a loading control.
Secretion and translocation assays. A ‘‘sewing’’ PCR reaction was
used to fuse IpaJ plus its upstream 500 nucleotides to a triple FLAG
tag at its carboxy terminus. This fusion gene was cloned into pAM238
(pSC101 ori) and the resulting plasmid was introduced into wild-type
and BS547 (MxiM::aphA-3) [50] 2457T Shigella ﬂexneri serotype 2a. To
determine if IpaJ-FLAG was secreted by the Shigella strains, overnight
cultures grown in TCS (trypticase soy) broth were diluted 1:100 into 6
mls TCS broth. The diluted cultures were grown for 2 hours until they
reached an OD600 of ;0.5. The bacteria were resuspended in 2 mls
phosphate-buffered saline (PBS) containing 10 uM Congo red (CR)
(Sigma) and incubated for an additional 30 minutes. All incubations
were conducted at 378C. After this incubation the bacteria were
centrifuged and the pellets were saved for the whole-cell lysates. The
supernatant was then subjected to a second centrifugation step to
ensure that few Shigella were present in the supernatant fraction.
Proteins present in the second supernatant were precipitated by the
addition of TCA (trichloroacetate). Proteins were analyzed by
Western blotting with an anti-FLAG antibody (Sigma).
For translocation assays, HeLa cells were infected (MOI of 1:100)
for 1 hour with wild-type and BS547 (MxiM::aphA-3) Shigella that
express IpaJ-FLAG. To synchronize infections and increase the
efﬁciency of invasion, a plasmid that expresses, the plasmid pIL22
that constitutively expresses the aﬁmbrial adhesin from uropatho-
genic E. coli was introduced into the Shigella strains [54]. Cells were
washed with ice cold PBS and then lysed with 300 ul RIPA buffer plus
protease inhibitors. The cells were spun down and the pellet was
designated the insoluble fraction. The supernatant was spun down a
second time and the result supernatant was designated the soluble
fraction. Equal volumes of soluble and insoluble fractions were
subjected to SDS-PAGE. Gels were blotted to nitrocellulose and
probed with the anti-FLAG antibody (Sigma).
Supporting Information
Figure S1. Correction of OD600 Readings at High Densities
A series of dilution measurements was conducted to derive a
correction equation to correct for the loss of linearity of OD600
readings at higher yeast culture densities (A). The mean value of eight
separate dilutions at each concentration level was taken to represent
OD600 at that dilution, and a line was ﬁt by simple regression to the
ﬁrst nine data points judged by eye to represent the most linear
range. The dotted line maps concentration, c,t o‘‘correct’’ optical
density, dcor, simply extrapolating the linearity of low concentrations
into the high range.
f:c ! dcor where f(x) ¼ a1x þ a0
A cubic polynomial was ﬁt by least squares regression to the entire 25
data points. For convenience in forming the function composition
that yields our correction equation, the ﬁt polynomial is actually the
inverse of that depicted. That is it maps the observed density (the y-
axis) to concentration (the x-axis).
g:dobs ! c where g(x) ¼ b3x
3 þ b2x
2 þb1xþb0
The correction equation is then simply the composition of these two
functions:
h ¼ f(g):dobs ! dcor where h(x) ¼ 0.453x
3   0.230x
2 þ 1.009x 0.002
Finally, the OD600 of empty media is subtracted to zero the result
yielding:
h(x) ¼ 0.453x
3 – 0.230x
2 þ 1.009x 0.035
(B) The correction curve is depicted along with the y ¼ x curve. The
correction curve crosses y ¼ x at 0.657.
Found at doi:10.1371/journal.ppat.0040009.sg001 (31 KB PDF).
Figure S2. Growth Curves of Yeast Expressing High Levels of Shigella
GFP Fusion Proteins in 96-Well Plates
Growth assays were conducted on 22 independent yeast trans-
formants that each conditionally express one of the GFP-Shigella
fusion proteins. The OD600 of each well was read at t¼24, 32, 40, 48,
and 52 h after the induction of expression of the fusion proteins. The
growth curves were spline-interpolated from the mean OD600 at each
of the ﬁve time points.
Found at doi:10.1371/journal.ppat.0040009.sg002 (36 KB PDF).
Figure S3. Yeast Growth Phenotypes Conferred by Low-Level
Expression of Shigella GFP Fusion Proteins from a Gateway-Derived
Vector
Each box-and-whisker plot summarizes the OD600 measurements of
six independent yeast cultures expressing the same bacterial protein
at t¼48 h. The boxes enclose approximately one quartile either side
of the median. The whiskers delimit the ;95% conﬁdence interval
for the mean (using default rendering parameters in the statistical
computing software package R [55]).
Found at doi:10.1371/journal.ppat.0040009.sg003 (34 KB PDF).
Figure S4. Growth Phenotypes Conferred by Expression of Francisella
GFP Fusion Proteins in Yeast
This blow up displays the ﬁrst 100 yeast strains expressing the
Francisella proteins when ordered by their mean OD600 reading. Each
box-and-whisker plot summarizes the OD600 measurements of six
independent yeast cultures expressing the same bacterial protein at t
¼ 48 h. The boxes enclose approximately one quartile either side of
the median. The whiskers delimit the ;95% conﬁdence interval for
the mean (using default rendering parameters in the statistical
computing software package R [55]).
Found at doi:10.1371/journal.ppat.0040009.sg004 (298 KB PDF).
Figure S5. Expression of Shigella and Francisella Proteins in Yeast
Overnight cultures of yeast that conditionally express GFP fused to
each of the 19 translocated and 20 non-translocated Shigella proteins
studied as well as 48 of the Francisella proteins were grown under non-
inducing conditions (2% rafﬁnose). In the AM, expression of the
recombinant proteins was induced by the addition of 4% galactose to
exponentially growing cultures for 4 h. Total protein was extracted
and resolved by SDS-PAGE. The proteins were analyzed by western
blot analyses using polyclonal anti-GFP antibody (BD Living Colors
full-length A. v. polyclonal Ab) (Clontech). A white dot is shown next
to the approximate size of the expected GFP fusion protein. Levels of
Cdc2 p34 (PSTAIRE) were monitored as a loading control (Santa Cruz
Biotechnology, Inc.).
Found at doi:10.1371/journal.ppat.0040009.sg005 (9.4 MB PDF).
Table S1. Summary of Growth Phenotypes Resulting from Expression
of Francisella Proteins in Yeast
Found at doi:10.1371/journal.ppat.0040009.st001 (276 KB XLS).
Table S2. Summary of Nucleotide and Amino Acid Changes in
Cloned Shigella ﬂexneri Genes/Proteins
Found at doi:10.1371/journal.ppat.0040009.st002 (35 KB DOC).
Accession Number
The GenBank accession number for the Shigella virulence plasmid
that encodes both the translocated and non-translocated proteins is
gij31983523:106938.
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